Skip to main content
Clinical Trials/CTRI/2023/01/048927
CTRI/2023/01/048927
Not yet recruiting
Phase 2

A Single Arm Clinical Study to evaluate the efficacy of Herbal Formulation (Capsule Punarnavadi Mishran) in management of Primary Hypertension.

Dr. Anuja Jain0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Sponsor
Dr. Anuja Jain
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr. Anuja Jain

Eligibility Criteria

Inclusion Criteria

  • 1\-Systolic blood pressure: \<170 mmHg to \>\= 140 mmHg.
  • 2\- Diastolic blood pressure: \<\= 110 mmHg to \> 90 mmHg.
  • 3\-Hypertension related to unknown origin.
  • 4\-Recently or newly diagnosed patient.

Exclusion Criteria

  • 1\-Secondary hypertension.
  • 2\-Alcoholic and drug abusers.
  • 3\-Accelerated and malignant hypertension.
  • 4\-Women who are pregnant or lactating or on estrogen replacement therapy.
  • 5\-Symptomatic patient with clinical feature of early heart failure.
  • 6\-Patient who have past history of cardiac diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials